Affiliation:
1. Department of Pharmaceutics Dalian Women and Children's Medical Group Dalian Liaoning China
2. College of Pharmacy Dalian Medical University Dalian Liaoning China
3. Department of Emergency Medicine Dalian Women and Children's Medical Group Dalian Liaoning China
Abstract
AbstractBackgroundFructose‐1,6‐bisphosphatase (FBPase) deficiency, caused by an FBP1 mutation, is an autosomal recessively inherited metabolic disorder characterized by impaired gluconeogenesis. Due to the rarity of FBPase deficiency, the mechanism by which the mutations cause enzyme activity loss still remains unclear.MethodsWe report a pediatric patient with typical FBPase deficiency who presented with hypoglycemia, hyperlactatemia, metabolic acidosis, and hyperuricemia. Whole‐exome sequencing was used to search for pathogenic genes, Sanger sequencing was used for verification, and molecular dynamic simulation was used to evaluate how the novel mutation affects FBPase activity and structural stability.ResultsDirect and allele‐specific sequence analysis of the FBP1 gene (NM_000507) revealed that the proband had a compound heterozygote for the c. 490 (exon 4) G>A (p. G164S) and c. 861 (exon 7) C>A (p. Y287X, 52), which he inherited from his carrier parents. His father and mother had heterozygous G164S and Y287X mutations, respectively, without any symptoms of hypoglycemia.ConclusionOur results broaden the known mutational spectrum and possible clinical phenotype of FBP1.
Funder
Dalian Science and Technology Bureau
Subject
Genetics (clinical),Genetics,Molecular Biology